Good
Mostly Aligned
Patient Risk:
Low
Summary
The AI response correctly matches the key counseling claim that Microgestin does not protect against HIV/AIDS or other sexually transmitted diseases to the provided label excerpt. However, the response contains some internal inconsistency and does not clearly limit evaluation strictly to the portions of labeling it cites with sufficient specificity.
Category Scores
Accurate Statements
Microgestin (like all oral contraceptives) is intended to prevent pregnancy.
Label excerpt: "This product (like all oral contraceptives) is intended to prevent pregnancy." (Patient counseling language embedded in labeling)
Microgestin does not protect against HIV infection (AIDS) and other sexually transmitted diseases.
Label excerpt PRECAUTIONS, 1: "Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases."
The labeling includes patient counseling language stating Microgestin does not protect against HIV/AIDS and other sexually transmitted diseases.
Label excerpt (patient counseling language embedded in labeling): "It does not protect against HIV infection (AIDS) and other sexually transmitted diseases."
Unsupported Statements
The specific FDA-approved prescribing information repository identifier is not retrievable from the text you supplied alone; below I extract only the sections relevant to your claim from the provided label text.
This is about the ability to retrieve an external repository identifier and is not supported or verifiable from the provided label excerpts.
Only one label reference is sufficiently specific to verify... the entries labeled as 'Patient counseling language (embedded in labeling)' do not provide verifiable section numbering; therefore, I cannot confirm their exact label section citations.
While exact section numbering is partly ambiguous in the provided prompt, the label text excerpts themselves explicitly contain the claim. The stated inability to verify section citations is not necessary to verify the factual content of the claim.
Contradictions
Important Omissions
The AI response does not provide a single consistent evaluation outcome; it includes two separate claim_evaluation blocks with different result fields ('supported' then 'not_verified'), creating uncertainty about the final verification conclusion.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The only substantive drug-label claim evaluated is a counseling statement about lack of HIV/STD protection, which is supported by the provided labeling excerpt. No dosing, contraindications, or safety risks were incorrectly stated.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Conflicting evaluation outputs ('supported' vs 'not_verified') within the same response; insufficiently consistent methodology for citation verification.
Suggested Improvement
Return a single consolidated verification result, and base support/contradiction strictly on the provided label text excerpts for the specific claim, without requiring additional external citation granularity.